Cargando…
Low Molecular Weight Fucoidan Inhibits Pulmonary Fibrosis In Vivo and In Vitro via Antioxidant Activity
In this study, sulfated polysaccharides extracted from Laminaria japonica were degraded by free radicals to obtain low molecular weight fucoidan (LMWF). The in vivo and in vitro effects of LMWF on bleomycin-treated pulmonary fibrosis mice and TGF-treated A549 cells, respectively, were evaluated, and...
Autores principales: | Dong, Huidan, Xue, Tao, Liu, Yanjuan, He, Shan, Yi, Yanliang, Zhang, Bo, Xin, Jie, Wang, Zhen, Li, Xinpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906950/ https://www.ncbi.nlm.nih.gov/pubmed/35281460 http://dx.doi.org/10.1155/2022/7038834 |
Ejemplares similares
-
Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism
por: Wang, Yan, et al.
Publicado: (2021) -
Toxicological Evaluation of Low Molecular Weight Fucoidan in Vitro and in Vivo
por: Hwang, Pai-An, et al.
Publicado: (2016) -
The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations
por: Lin, Yuan, et al.
Publicado: (2020) -
Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In Vivo
por: Xue, Meilan, et al.
Publicado: (2012) -
In Vitro and In Vivo Dendritic Cell Immune Stimulation Effect of Low Molecular Weight Fucoidan from New Zealand Undaria pinnatifida
por: Liu, Litong, et al.
Publicado: (2022)